CPT code 87527 identifies a molecular diagnostic assay that quantifies Hepatitis G virus (HGV/GBV) using a nucleic acid probe. This code is used by clinical and hospital laboratories to document testing for HGV infection, which is typically asymptomatic or associated with mild hepatitis. As molecular viral assays remain central to diagnosis and public health surveillance, correct coding of 87527 ensures appropriate claims processing and clinical communication nationwide.

Key payers in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise account of the clinical context for HGV testing, common sites of service, and what to expect in terms of coding classification. The publication covers benchmarks for utilization and reimbursement patterns where available, recent policy and coverage considerations affecting molecular virology codes, and operational implications for laboratories and billing teams.

This summary provides clinicians, laboratory managers, and billing professionals with the clinical purpose of the code, the primary settings where the service is performed, and the scope of payer coverage included in the analysis. Data not available in the input is noted where relevant.